These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19574343)

  • 21. Association between serum 25-hydroxyvitamin D and serum sex steroid hormones among men in NHANES.
    Anic GM; Albanes D; Rohrmann S; Kanarek N; Nelson WG; Bradwin G; Rifai N; McGlynn KA; Platz EA; Mondul AM
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):258-66. PubMed ID: 26991691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in sex hormone concentrations in US males: 1988-1991 to 1999-2004.
    Nyante SJ; Graubard BI; Li Y; McQuillan GM; Platz EA; Rohrmann S; Bradwin G; McGlynn KA
    Int J Androl; 2012 Jun; 35(3):456-66. PubMed ID: 22150314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies.
    Eaton NE; Reeves GK; Appleby PN; Key TJ
    Br J Cancer; 1999 Jun; 80(7):930-4. PubMed ID: 10362098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of serum calcium with serum sex steroid hormones in men in NHANES III.
    Van Hemelrijck M; Michaelsson K; Nelson WG; Kanarek N; Dobs A; Platz EA; Rohrmann S
    Aging Male; 2013 Dec; 16(4):151-8. PubMed ID: 23672276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
    Kaaks R; Tikk K; Sookthai D; Schock H; Johnson T; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Dossus L; Baglietto L; Rinaldi S; Chajes V; Romieu I; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Tumino R; Ricceri F; Mattiello A; Buckland G; Ramón Quirós J; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bas Bueno-de-Mesquita H; van Gils CH; Peeters PH; Andersson A; Sund M; Weiderpass E; Khaw KT; Wareham N; Key TJ; Travis RC; Merritt MA; Gunter MJ; Riboli E; Lukanova A
    Int J Cancer; 2014 Apr; 134(8):1947-57. PubMed ID: 24155248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of nutritional factors on sex hormone levels in male twins.
    Bishop DT; Meikle AW; Slattery ML; Stringham JD; Ford MH; West DW
    Genet Epidemiol; 1988; 5(1):43-59. PubMed ID: 3360302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3).
    Beckmann L; Hüsing A; Setiawan VW; Amiano P; Clavel-Chapelon F; Chanock SJ; Cox DG; Diver R; Dossus L; Feigelson HS; Haiman C; Hallmans G; Hayes RB; Henderson BE; Hoover RN; Hunter DJ; Khaw K; Kolonel LN; Kraft P; Lund E; Le Marchand L; Peeters PH; Riboli E; Stram D; Thomas G; Thun MJ; Tumino R; Trichopoulos D; Vogel U; Willett WC; Yeager M; Ziegler R; Hankinson SE; Kaaks R;
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E360-7. PubMed ID: 21177793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Racial variation in sex steroid hormone concentration in black and white men: a meta-analysis.
    Richard A; Rohrmann S; Zhang L; Eichholzer M; Basaria S; Selvin E; Dobs AS; Kanarek N; Menke A; Nelson WG; Platz EA
    Andrology; 2014 May; 2(3):428-35. PubMed ID: 24648111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Lindström S; Ma J; Altshuler D; Giovannucci E; Riboli E; Albanes D; Allen NE; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Chanock SJ; Dunning AM; Feigelson HS; Gaziano JM; Haiman CA; Hayes RB; Henderson BE; Hunter DJ; Kaaks R; Kolonel LN; Le Marchand L; Martínez C; Overvad K; Siddiq A; Stampfer M; Stattin P; Stram DO; Thun MJ; Trichopoulos D; Tumino R; Virtamo J; Weinstein SJ; Yeager M; Kraft P; Freedman ML
    J Clin Endocrinol Metab; 2010 Sep; 95(9):E121-7. PubMed ID: 20534771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.
    Kristal AR; Schenk JM; Song Y; Arnold KB; Neuhouser ML; Goodman PJ; Lin DW; Stanczyk FZ; Thompson IM
    Am J Epidemiol; 2008 Dec; 168(12):1416-24. PubMed ID: 18945688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age, genetic, and nongenetic factors influencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins.
    Meikle AW; Stephenson RA; Lewis CM; Wiebke GA; Middleton RG
    Prostate; 1997 Oct; 33(2):105-11. PubMed ID: 9316651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of polymorphisms in selected genes involved in pituitary-testicular function on reproductive hormones and phenotype in aging men.
    Huhtaniemi IT; Pye SR; Holliday KL; Thomson W; O'Neill TW; Platt H; Payne D; John SL; Jiang M; Bartfai G; Boonen S; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Vanderschueren D; Labrie F; Wu FC;
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1898-908. PubMed ID: 20173016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.
    Watts EL; Appleby PN; Albanes D; Black A; Chan JM; Chen C; Cirillo PM; Cohn BA; Cook MB; Donovan JL; Ferrucci L; Garland CF; Giles GG; Goodman PJ; Habel LA; Haiman CA; Holly JMP; Hoover RN; Kaaks R; Knekt P; Kolonel LN; Kubo T; Le Marchand L; Luostarinen T; MacInnis RJ; Mäenpää HO; Männistö S; Metter EJ; Milne RL; Nomura AMY; Oliver SE; Parsons JK; Peeters PH; Platz EA; Riboli E; Ricceri F; Rinaldi S; Rissanen H; Sawada N; Schaefer CA; Schenk JM; Stanczyk FZ; Stampfer M; Stattin P; Stenman UH; Tjønneland A; Trichopoulou A; Thompson IM; Tsugane S; Vatten L; Whittemore AS; Ziegler RG; Allen NE; Key TJ; Travis RC
    PLoS One; 2017; 12(12):e0187741. PubMed ID: 29281666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer.
    Lévesque É; Laverdière I; Lacombe L; Caron P; Rouleau M; Turcotte V; Têtu B; Fradet Y; Guillemette C
    Clin Cancer Res; 2014 Feb; 20(3):576-84. PubMed ID: 24277450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
    ; Roddam AW; Allen NE; Appleby P; Key TJ
    J Natl Cancer Inst; 2008 Feb; 100(3):170-83. PubMed ID: 18230794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden).
    Manjer J; Johansson R; Berglund G; Janzon L; Kaaks R; Agren A; Lenner P
    Cancer Causes Control; 2003 Sep; 14(7):599-607. PubMed ID: 14575357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes.
    Perry JR; Weedon MN; Langenberg C; Jackson AU; Lyssenko V; Sparsø T; Thorleifsson G; Grallert H; Ferrucci L; Maggio M; Paolisso G; Walker M; Palmer CN; Payne F; Young E; Herder C; Narisu N; Morken MA; Bonnycastle LL; Owen KR; Shields B; Knight B; Bennett A; Groves CJ; Ruokonen A; Jarvelin MR; Pearson E; Pascoe L; Ferrannini E; Bornstein SR; Stringham HM; Scott LJ; Kuusisto J; Nilsson P; Neptin M; Gjesing AP; Pisinger C; Lauritzen T; Sandbaek A; Sampson M; ; Zeggini E; Lindgren CM; Steinthorsdottir V; Thorsteinsdottir U; Hansen T; Schwarz P; Illig T; Laakso M; Stefansson K; Morris AD; Groop L; Pedersen O; Boehnke M; Barroso I; Wareham NJ; Hattersley AT; McCarthy MI; Frayling TM
    Hum Mol Genet; 2010 Feb; 19(3):535-44. PubMed ID: 19933169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consumption of caffeinated beverages and serum concentrations of sex steroid hormones in US men.
    Frey T; Platz EA; Kanarek N; Bradwin G; Dobs AS; Rohrmann S
    Cancer Causes Control; 2018 Jan; 29(1):157-166. PubMed ID: 29177989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.
    Canzian F; Cox DG; Setiawan VW; Stram DO; Ziegler RG; Dossus L; Beckmann L; Blanché H; Barricarte A; Berg CD; Bingham S; Buring J; Buys SS; Calle EE; Chanock SJ; Clavel-Chapelon F; DeLancey JO; Diver WR; Dorronsoro M; Haiman CA; Hallmans G; Hankinson SE; Hunter DJ; Hüsing A; Isaacs C; Khaw KT; Kolonel LN; Kraft P; Le Marchand L; Lund E; Overvad K; Panico S; Peeters PH; Pollak M; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Yeager M; Hoover RN; Riboli E; Thomas G; Henderson BE; Kaaks R; Feigelson HS
    Hum Mol Genet; 2010 Oct; 19(19):3873-84. PubMed ID: 20634197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia.
    Hayes VM; Severi G; Padilla EJ; Morris HA; Tilley WD; Southey MC; English DR; Sutherland RL; Hopper JL; Boyle P; Giles GG
    Int J Cancer; 2007 Feb; 120(4):776-80. PubMed ID: 17136762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.